Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT07023666

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Led by Inova Health Care Services · Updated on 2025-10-14

100

Participants Needed

2

Research Sites

90 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.

CONDITIONS

Official Title

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 18 years of age
  • Diagnosed with sickle cell disease of any genotype
  • Serum ferritin levels 2400 ng/mL (up to 80 patients) or less than 400 ng/mL with cardiac symptoms like shortness of breath or leg swelling (up to 20 patients)
  • Willing to undergo regular cardiac imaging including echocardiograms, ECG, and cardiac MRI
  • ECOG performance status of 0 to 1
  • Able to read, understand, and provide written informed consent
  • Approved for participation by the treating physician
Not Eligible

You will not qualify if you...

  • Unable to attend scheduled follow-up visits
  • Known heart failure
  • Unstable angina
  • Uncontrolled dysrhythmias
  • Acute pulmonary embolism
  • Active infection or severe medical conditions that might limit study participation
  • History of allergy or contraindication to chelation therapy
  • Severe kidney or liver impairment
  • Pregnancy or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Inova Schar Cancer

Fairfax, Virginia, United States, 22031

Actively Recruiting

2

Inova Health Care Service

Falls Church, Virginia, United States, 22042

Actively Recruiting

Loading map...

Research Team

K

Keary Jane't

CONTACT

E

Elahe Mollapour

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here